February 7, 2018 / 2:25 PM / 2 months ago

BRIEF-Auris Medical Reports New Data Highlighting Superior Bioavailability Of AM-125

Feb 7 (Reuters) - Auris Medical Holding AG:

* AURIS MEDICAL REPORTS NEW DATA HIGHLIGHTING SUPERIOR BIOAVAILABILITY OF AM-125 COMPARED TO ORAL BETAHISTINE

* AURIS MEDICAL HOLDING - SINGLE DOSE ANIMAL STUDY DEMONSTRATES 5 TO 35 TIMES HIGHER BIOAVAILABILITY OF INTRANASAL BETAHISTINE RELATIVE TO ORAL BETAHISTINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below